EGRIFTA WR

pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment, traumatic brain inj Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment, traumatic brain injury, nonalcoholic steathohepatitis and nonalcoholic fatty liver disease.

Mark Details

Serial Number

UK00003807925

Mark Type

Word

Kind of mark

Individual